Table 2.

Logistic regression analysis of association between clinicopathological characteristics and RPP40 expression in UCEC patients.

Characteristics	Odds Ratio (95%CI)	P-value
Clinical stage (Stage III–IV vs. Stage I–II)	1.617 (1.116-2.353)	0.011
Histologic grade (G3 vs. G1–2)	3.280 (2.293-4.724)	<0.001
Histological type (Mixed and Serous vs. Endometrioid)	3.166 (2.114-4.808)	<0.001
Age (>60 vs. ≤60)	1.374 (0.972-1.945)	0.073
BMI (>30 vs. ≤30)	0.774 (0.544-1.099)	0.152
Menopause status (Post vs. Pre and Peri)	1.413 (0.794-2.549)	0.243
Primary therapy outcome (PD and SD and PR vs. CR)	2.864 (1.422-6.156)	0.004
Residual tumor (R1 and R2 vs. R0)	1.178 (0.603-2.317)	0.630
Tumor invasion (%) (≥50 vs. <50)	0.915 (0.636-1.314)	0.630
Hormones therapy (Yes vs. No)	0.736 (0.391-1.364)	0.333
Diabetes (Yes vs. No)	1.221 (0.806-1.851)	0.346
Radiation therapy (Yes vs. No)	1.020 (0.724-1.436)	0.910
Surgical approach (Open vs. Minimally Invasive)	0.957 (0.675-1.356)	0.804